ALGERT GLOBAL LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 154 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$44,000
+4.8%
37,5500.0%0.00%0.0%
Q2 2022$42,000
-90.2%
37,550
-73.8%
0.00%
-89.3%
Q1 2022$429,000
+725.0%
143,592
+845.3%
0.03%
+64.7%
Q1 2021$52,000
-69.8%
15,190
-79.0%
0.02%
-65.3%
Q4 2016$172,000
-86.0%
72,249
-78.3%
0.05%
-86.2%
Q3 2016$1,225,000
+121.9%
333,657
+34.9%
0.35%
+58.0%
Q2 2016$552,000
+101.5%
247,340
+87.5%
0.22%
+117.5%
Q1 2016$274,000
+64.1%
131,889
+140.0%
0.10%
+32.1%
Q4 2015$167,000
+22.8%
54,9600.0%0.08%
+4.0%
Q3 2015$136,000
-22.7%
54,9600.0%0.08%
-22.7%
Q2 2015$176,000
-10.2%
54,9600.0%0.10%
-11.0%
Q1 2015$196,000
+553.3%
54,960
+318.9%
0.11%
+505.6%
Q4 2014$30,000
+20.0%
13,1200.0%0.02%
-5.3%
Q3 2014$25,000
-47.9%
13,1200.0%0.02%
-38.7%
Q2 2014$48,00013,1200.03%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders